Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Ponting

Diagnostic Radiology Nashville, TN Medical Doctor

NPI 1285072280 CMS profile 656741

3601 The Vanderbilt Clinic, Nashville, TN 37232

Open in the dashboard

General payments

$12,100

183 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Ponting of Nashville, TN is reported in the CMS Open Payments database as having received $12,100 across 183 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,015 37
2024 General $3,754 81
2023 General $5,269 52
2022 General $815 3
2021 General $866 5
2020 General $66 2
2019 General $314 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Ponting
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to John Ponting were reported at $1,015. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year John Ponting Diagnostic Radiology median Middle half National median
2019 $314 $108 $29–$318 $163
2020 $66 $65 $21–$252 $114
2021 $866 $92 $24–$292 $132
2022 $815 $104 $29–$294 $149
2023 $5,269 $110 $29–$337 $160
2024 $3,754 $113 $30–$356 $164
2025 $1,015 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $4,581 69 payments
  2. Penumbra, Inc. $4,105 33 payments
  3. Imperative Care, INc $1,005 23 payments
  4. Stryker Corporation $568 22 payments
  5. Balt USA, LLC $549 4 payments
  6. Terumo Medical Corporation $291 2 payments
  7. Medtronic, Inc. $271 11 payments
  8. Surefire Medical, Inc. $195 3 payments
  9. Sirtex Medical Inc $175 3 payments
  10. Boston Scientific Corporation $150 3 payments
  11. Other $212 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $11,187 182 payments
  2. Travel and Lodging $913 1 payment
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $5,175 89 payments
  2. CT THROMBECTOMY SYSTEM KIT $4,750 87 payments
  3. Indigo System $2,948 22 payments
  4. ZOOM 88-T LARGE DISTAL PLATFORM $696 12 payments
  5. Penumbra System $541 4 payments
  6. RED 72 $449 3 payments
  7. Prestige Coil System $374 3 payments
  8. Optima Coil System $351 2 payments
  9. TR Band $291 2 payments
  10. AZUR $291 2 payments
  11. Other $2,261 52 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 207 billing codes

Paid by Medicare

$99,436

Of which drugs: $692

Medicare patients

1,439

Average age 76

Services billed

7,137

819 women, 620 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 64%
Ischemic heart disease 53%
Diabetes 46%
Chronic kidney disease 45%
Depression 42%
Heart failure 38%
Atrial fibrillation 34%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 42 4,210 $434
Injection, gadobutrol, 0.1 ml A9585 Office 13 965 $257

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SPINRAZA
  • Biogen, Inc. $23
$23 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

183 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record